Jiangzhong Pharmaceutical Co Ltd (600750) — Cash Flow-to-Debt Ratio
Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of CN¥-2.91 Million could theoretically repay 0% of its total liabilities (CN¥2.18 Billion) in one year. See 600750 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangzhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Jiangzhong Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Jiangzhong Pharmaceutical Co Ltd (600750) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Jiangzhong Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Jiangzhong Pharmaceutical Co Ltd. Check 600750 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥970.87 Million | CN¥2.18 Billion | ▲ +15.5% |
| 2024 | 0.39x | CN¥786.25 Million | CN¥2.04 Billion | ▼ -33.9% |
| 2023 | 0.58x | CN¥1.04 Billion | CN¥1.77 Billion | ▲ +1.1% |
| 2022 | 0.58x | CN¥1.02 Billion | CN¥1.77 Billion | ▼ -10.8% |
| 2021 | 0.65x | CN¥917.04 Million | CN¥1.42 Billion | ▼ -42.1% |
| 2020 | 1.12x | CN¥752.50 Million | CN¥672.27 Million | ▲ +45.7% |
| 2019 | 0.77x | CN¥641.18 Million | CN¥834.84 Million | ▼ -11.0% |
| 2018 | 0.86x | CN¥486.25 Million | CN¥563.53 Million | ▲ +209.9% |
| 2017 | 0.28x | CN¥124.93 Million | CN¥448.74 Million | ▼ -82.1% |
| 2016 | 1.55x | CN¥698.05 Million | CN¥449.96 Million | ▼ -1.7% |
| 2015 | 1.58x | CN¥510.78 Million | CN¥323.74 Million | ▲ +427.9% |
| 2014 | 0.30x | CN¥356.80 Million | CN¥1.19 Billion | ▲ +129.4% |
| 2013 | 0.13x | CN¥111.92 Million | CN¥859.15 Million | ▼ -32.3% |
| 2012 | 0.19x | CN¥226.38 Million | CN¥1.18 Billion | ▼ -23.2% |
| 2011 | 0.25x | CN¥168.30 Million | CN¥671.11 Million | ▼ -18.0% |
| 2010 | 0.31x | CN¥222.29 Million | CN¥726.93 Million | ▼ -57.6% |
| 2009 | 0.72x | CN¥378.32 Million | CN¥524.73 Million | ▲ +65.4% |
| 2008 | 0.44x | CN¥268.87 Million | CN¥616.73 Million | ▲ +8.9% |
| 2007 | 0.40x | CN¥153.63 Million | CN¥383.89 Million | ▲ +312.9% |
| 2006 | 0.10x | CN¥55.24 Million | CN¥569.95 Million | ▼ -78.1% |
| 2005 | 0.44x | CN¥198.45 Million | CN¥449.20 Million | ▲ +743.4% |
| 2004 | 0.05x | CN¥26.28 Million | CN¥501.74 Million | ▼ -77.0% |
| 2003 | 0.23x | CN¥78.98 Million | CN¥347.14 Million | ▼ -60.3% |
| 2002 | 0.57x | CN¥94.90 Million | CN¥165.58 Million | ▲ +22.5% |
| 2001 | 0.47x | CN¥41.28 Million | CN¥88.23 Million | ▼ -37.5% |
| 2000 | 0.75x | CN¥121.77 Million | CN¥162.71 Million | ▲ +651.9% |
| 1999 | -0.14x | CN¥-21.89 Million | CN¥161.46 Million | ▼ -70.4% |
| 1998 | -0.08x | CN¥-11.42 Million | CN¥143.42 Million | — |